Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IDEAYA Biosciences (IDYA) Assets Average (2019 - 2025)

IDEAYA Biosciences (IDYA) has disclosed Assets Average for 7 consecutive years, with $1.1 billion as the latest value for Q4 2025.

  • Quarterly Assets Average fell 2.94% to $1.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 billion through Dec 2025, down 2.94% year-over-year, with the annual reading at $1.1 billion for FY2025, 25.94% up from the prior year.
  • Assets Average hit $1.1 billion in Q4 2025 for IDEAYA Biosciences, up from $1.1 billion in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $1.2 billion in Q4 2024 to a low of $312.2 million in Q1 2021.
  • Historically, Assets Average has averaged $666.8 million across 5 years, with a median of $488.2 million in 2023.
  • Biggest five-year swings in Assets Average: surged 190.68% in 2021 and later decreased 2.94% in 2025.
  • Year by year, Assets Average stood at $390.4 million in 2021, then rose by 2.32% to $399.4 million in 2022, then skyrocketed by 47.99% to $591.1 million in 2023, then skyrocketed by 99.95% to $1.2 billion in 2024, then decreased by 2.94% to $1.1 billion in 2025.
  • Business Quant data shows Assets Average for IDYA at $1.1 billion in Q4 2025, $1.1 billion in Q3 2025, and $1.1 billion in Q2 2025.